联亚药业
(301569)
| 流通市值：24.83亿 | | | 总市值：189.46亿 |
| 流通股本：1.17亿 | | | 总股本：8.92亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 746,953,750.18 | 491,831,812.75 | 234,677,000 | 895,470,048.65 |
| 营业收入 | 746,953,750.18 | 491,831,812.75 | - | 895,470,048.65 |
| 二、营业总成本 | 495,117,852.61 | 323,570,067.89 | - | 616,368,836.41 |
| 营业成本 | 302,468,295.81 | 187,835,740.88 | - | 396,438,341.42 |
| 税金及附加 | 7,466,443.65 | 3,715,740.48 | - | 4,829,420.34 |
| 销售费用 | 7,323,743.04 | 4,358,238.01 | - | 12,503,450.12 |
| 管理费用 | 91,857,239.22 | 62,377,155.33 | - | 115,160,137.69 |
| 研发费用 | 67,484,721.19 | 50,050,008.57 | - | 100,974,183.41 |
| 财务费用 | 18,517,409.7 | 15,233,184.62 | - | -13,536,696.57 |
| 其中:利息收入 | 29,905,206.1 | 18,881,997.48 | - | - |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -139,991.1 | -117,295.21 | - | 6,317.82 |
| 加:投资收益 | 894,121.32 | 630,298.15 | - | 2,495,142.57 |
| 资产减值损失(新) | 2,490,727.36 | -6,688,861 | - | -19,257,026.74 |
| 信用减值损失(新) | 845,922.45 | 1,429,321.55 | - | -1,633,724.98 |
| 其他收益 | 1,272,910.15 | 657,124.18 | - | 2,120,309.04 |
| 营业利润平衡项目 | 0 | 0 | - | 0 |
| 四、营业利润 | 257,199,587.75 | 164,172,332.53 | 73,153,800 | 262,832,229.95 |
| 加:营业外收入 | 240,578.23 | 195,250.8 | - | 464,544.38 |
| 减:营业外支出 | 58,835.9 | 8,053.77 | - | 164,242.17 |
| 利润总额平衡项目 | 0 | 0 | - | 0 |
| 五、利润总额 | 257,381,330.08 | 164,359,529.56 | 73,284,200 | 263,132,532.16 |
| 减:所得税费用 | 30,971,826.71 | 23,331,840.61 | - | 35,313,494.12 |
| 六、净利润 | 226,409,503.37 | 141,027,688.95 | - | 227,819,038.04 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 226,409,503.37 | 141,027,688.95 | - | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 226,409,503.37 | 141,027,688.95 | 63,188,500 | 227,819,038.04 |
| 扣除非经常损益后的净利润 | 224,470,528.6 | 139,832,563.45 | 62,520,000 | 222,995,036.98 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.3 | - | - | 0.3 |
| (二)稀释每股收益 | 0.3 | - | - | 0.3 |
| 八、其他综合收益 | -920,957.21 | -681,513.46 | - | -488,396.77 |
| 归属于母公司股东的其他综合收益 | -920,957.21 | -681,513.46 | - | -488,396.77 |
| 九、综合收益总额 | 225,488,546.16 | 140,346,175.49 | - | 227,330,641.27 |
| 归属于母公司股东的综合收益总额 | 225,488,546.16 | 140,346,175.49 | - | 227,330,641.27 |
| 公告日期 | 2026-10-30 | 2026-09-17 | 2026-07-02 | 2026-06-12 |
| 审计意见(境内) | | | | 标准无保留意见 |